This WHO guideline provides evidence-based recommendations on the intermittent use of iron–folic acid supplements as a public health measure for the purpose of reducing anemia and improving iron status among menstruating women.

The guideline is intended for a wide audience, including policymakers, expert advisers, and technical and program staff at organizations involved in the design, implementation, and scale-up of nutrition actions for public health.